Probability of Ten-Year Survival in Metastatic Renal Cell Carcinoma

Publisher： Karger

E-ISSN： 1423-0399|80|3|335-337

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.80, Iss.3, 2008-05, pp. : 335-337

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Progression‐free survival as a surrogate endpoint of overall survival in patients with metastatic renal cell carcinoma

By  

CANCER, Vol. 120, Iss. 1, 2014-01 ,pp. : 52-60

John Wiley & Sons Inc

Access to resources Recommend Favorite

p21‐activated kinase 1 predicts recurrence and survival in patients with non‐metastatic clear cell renal cell carcinoma

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 5, 2015-05 ,pp. : 447-453

John Wiley & Sons Inc

Access to resources Recommend Favorite

Five-Year Survival Results of Subcutaneous Low-Dose Immunotherapy with Interleukin-2 Alone in Metastatic Renal Cell Cancer Patients

By  

Urologia Internationalis, Vol. 64, Iss. 1, 2000-04 ,pp. : 3-8

Karger

Access to resources Recommend Favorite

Ramucirumab in metastatic renal cell carcinoma: The beginning or the end?

By  

CANCER, Vol. 120, Iss. 11, 2014-06 ,pp. : 1604-1607

John Wiley & Sons Inc

Access to resources Recommend Favorite

Urologic Approaches to Metastatic Renal Cell Carcinoma

By  

Oncology Research and Treatment, Vol. 24, Iss. 2, 2001-05 ,pp. : 122-126

Karger

Access to resources Recommend Favorite